169 related articles for article (PubMed ID: 34153318)
1. Acceptability of the oral hormonal male contraceptive prototype, 11β-methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC), in a 28-day placebo-controlled trial.
Nguyen BT; Yuen F; Farrant M; Thirumalai A; Fernando F; Amory JK; Swerdloff RS; Anawalt BD; Blithe DL; Long JE; Liu PY; Page ST; Wang C
Contraception; 2021 Nov; 104(5):531-537. PubMed ID: 34153318
[TBL] [Abstract][Full Text] [Related]
2. Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in Men.
Wu S; Yuen F; Swerdloff RS; Pak Y; Thirumalai A; Liu PY; Amory JK; Bai F; Hull L; Blithe DL; Anawalt BD; Parman T; Kim K; Lee MS; Bremner WJ; Page ST; Wang C
J Clin Endocrinol Metab; 2019 Mar; 104(3):629-638. PubMed ID: 30252057
[TBL] [Abstract][Full Text] [Related]
3. Male contraception is coming: Who do men want to prescribe their birth control?
Jacobsohn T; Nguyen BT; Brown JE; Thirumalai A; Massone M; Page ST; Wang C; Kroopnick J; Blithe DL
Contraception; 2022 Nov; 115():44-48. PubMed ID: 35550379
[TBL] [Abstract][Full Text] [Related]
4. Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins in Healthy Men.
Yuen F; Thirumalai A; Pham C; Swerdloff RS; Anawalt BD; Liu PY; Amory JK; Bremner WJ; Dart C; Wu H; Hull L; Blithe DL; Long J; Wang C; Page ST
J Clin Endocrinol Metab; 2020 Mar; 105(3):e835-47. PubMed ID: 31976519
[TBL] [Abstract][Full Text] [Related]
5. Acceptability of oral dimethandrolone undecanoate in a 28-day placebo-controlled trial of a hormonal male contraceptive prototype.
Nguyen BT; Farrant MT; Anawalt BD; Yuen F; Thirumalai A; Amory JK; Swerdloff RS; Bremner WJ; Liu PY; Blithe DL; Page ST; Wang C
Contraception; 2020 Jul; 102(1):52-57. PubMed ID: 32298717
[TBL] [Abstract][Full Text] [Related]
6. Comparison of metabolic effects of the progestational androgens dimethandrolone undecanoate and 11β-MNTDC in healthy men.
Yuen F; Thirumalai A; Fernando FA; Swerdloff RS; Liu PY; Pak Y; Hull L; Bross R; Blithe DL; Long JE; Page ST; Wang C
Andrology; 2021 Sep; 9(5):1526-1539. PubMed ID: 33908182
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of dimethandrolone 17β-undecanoate and 11β-methyl-19-nortestosterone 17β-dodecylcarbonate on body composition, bone mineral density, serum gonadotropins, and androgenic/anabolic activity in castrated male rats.
Attardi BJ; Marck BT; Matsumoto AM; Koduri S; Hild SA
J Androl; 2011; 32(2):183-92. PubMed ID: 20798389
[TBL] [Abstract][Full Text] [Related]
8. Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial.
Roth MY; Shih G; Ilani N; Wang C; Page ST; Bremner WJ; Swerdloff RS; Sitruk-Ware R; Blithe DL; Amory JK
Contraception; 2014 Oct; 90(4):407-12. PubMed ID: 24981149
[TBL] [Abstract][Full Text] [Related]
9. Hormonal male contraception: progress and prospects for the 21st century.
Handelsman DJ
Aust N Z J Med; 1995 Dec; 25(6):808-16. PubMed ID: 8770357
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen.
Amory JK; Page ST; Anawalt BD; Matsumoto AM; Bremner WJ
Contraception; 2007 Mar; 75(3):218-23. PubMed ID: 17303493
[TBL] [Abstract][Full Text] [Related]
11. Men's willingness to use novel male contraception is linked to gender-equitable attitudes: Results from an exploratory online survey.
Nguyen BT; Jacobsohn TL
Contraception; 2023 Jul; 123():110001. PubMed ID: 36924819
[TBL] [Abstract][Full Text] [Related]
12. Identifying determinants of Mozambican men's willingness to use a male contraceptive pill.
Vera Cruz G; Humeau A; Moore PJ; Mullet E
Eur J Contracept Reprod Health Care; 2019 Aug; 24(4):266-273. PubMed ID: 31204885
[No Abstract] [Full Text] [Related]
13. Design of an international male contraceptive efficacy trial using a self-administered daily transdermal gel containing testosterone and segesterone acetate (Nestorone).
Amory JK; Blithe DL; Sitruk-Ware R; Swerdloff RS; Bremner WJ; Dart C; Liu PY; Thirumalai A; Nguyen BT; Anawalt BD; Lee MS; Page ST; Wang C
Contraception; 2023 Aug; 124():110064. PubMed ID: 37210024
[TBL] [Abstract][Full Text] [Related]
14. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM; Nashan D; Hubert W; Nieschlag E
J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
[TBL] [Abstract][Full Text] [Related]
15. Canadian Contraception Consensus (Part 2 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
[TBL] [Abstract][Full Text] [Related]
16. Update on Novel Hormonal and Nonhormonal Male Contraceptive Development.
Long JE; Lee MS; Blithe DL
J Clin Endocrinol Metab; 2021 May; 106(6):e2381-e2392. PubMed ID: 33481994
[TBL] [Abstract][Full Text] [Related]
17. Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations.
Martin CW; Anderson RA; Cheng L; Ho PC; van der Spuy Z; Smith KB; Glasier AF; Everington D; Baird DT
Hum Reprod; 2000 Mar; 15(3):637-45. PubMed ID: 10686211
[TBL] [Abstract][Full Text] [Related]
18. Canadian Contraception Consensus (Part 1 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
[TBL] [Abstract][Full Text] [Related]
19. Combined nestorone-testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men.
Anawalt BD; Roth MY; Ceponis J; Surampudi V; Amory JK; Swerdloff RS; Liu PY; Dart C; Bremner WJ; Sitruk-Ware R; Kumar N; Blithe DL; Page ST; Wang C
Andrology; 2019 Nov; 7(6):878-887. PubMed ID: 30969032
[TBL] [Abstract][Full Text] [Related]
20. Male hormonal contraception. What prospects exist and how acceptable are they?
Griffin D; Ringheim K
Plan Parent Chall; 1996; (2):20-4. PubMed ID: 12291936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
